Table 46.
Treatment of withdrawal
| N (%)a | |
|---|---|
| Opioid withdrawal | |
| Buprenorphine | 31 (43.7) |
| Clonidine | 21 (29.6) |
| Methadone | 14 (19.7) |
| Naloxone OD kit | 3 (4.2) |
| Clonazepam | 1 (1.4) |
| Ondansetron | 1 (1.4) |
| Total | 71 (100) |
| Ethanol withdrawal | |
| Naltrexone | 3 (42.9) |
| Buprenorphine | 3 (42.9) |
| Clonidine | 1 (14.3) |
| Total | 7 (100) |
| Sedative-hypnotic withdrawal | |
| Phenobarbital | 1 (33.3) |
| Methadone | 1 (33.3) |
| Clonidine | 1 (33.3) |
| Total | 3 (100) |
aPercentage based on the total number of treatments administered (opioid N = 71, ethanol N = 7, sedative-hypnotic N = 3). Fifty-nine (0.8%) registry opioid withdrawal cases, 6 (0.1%) registry ethanol withdrawal cases, and 3 (0.0%) registry sedative-hypnotic cases received at least one type of withdrawal treatment